Combinations of AKT and MEK inhibitor compounds, and methods of use
US9682082B2 · kind B2 · utility
4Cited by
34References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2012 |
| Grant date | Jun 20, 2017 |
| Priority date | — |
| Expiry date | Mar 30, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides combinations comprising a) compound of formula I: (formula I), or a pharmaceutically acceptable salt thereof; and another agent selected from GDC-0973, PD-0325901, or a pharmaceutically acceptable salt thereof. The combinations are particularly useful for treating hyperproliferative disorders, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.